Chun-Shui Pan Selected Research

salvianolic acid

1/2019	Total Salvianolic Acid Injection Prevents Ischemia/Reperfusion-Induced Myocardial Injury Via Antioxidant Mechanism Involving Mitochondrial Respiratory Chain Through the Upregulation of Sirtuin1 and Sirtuin3.
10/2014	Role of NADPH oxidase in total salvianolic acid injection attenuating ischemia-reperfusion impaired cerebral microcirculation and neurons: implication of AMPK/Akt/PKC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Shui Pan Research Topics

Disease

19	Ischemia 06/2022 - 04/2010
12	Edema (Dropsy) 06/2022 - 09/2013
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2004
8	Reperfusion Injury 01/2021 - 09/2013
7	Cardiomegaly (Heart Hypertrophy) 01/2021 - 05/2006
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 09/2005
6	Fibrosis (Cirrhosis) 01/2019 - 05/2006
4	Body Weight (Weight, Body) 01/2022 - 01/2012
4	Hemorrhage 01/2022 - 12/2016
4	Ischemic Stroke 01/2021 - 10/2014
4	Hypertension (High Blood Pressure) 01/2013 - 02/2004
4	Heart Failure 11/2006 - 09/2004
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 10/2014
3	Hypoxia (Hypoxemia) 01/2022 - 01/2018
3	Brain Edema (Cerebral Edema) 01/2021 - 06/2015
3	Infarction (Infarctions) 01/2021 - 05/2006
3	Hypertrophy 01/2019 - 09/2005
3	Myocardial Infarction 01/2018 - 04/2010
3	Lung Injury 01/2018 - 11/2014
3	Necrosis 01/2017 - 01/2005
3	Sepsis (Septicemia) 12/2016 - 05/2004
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Rupture 01/2021 - 09/2013
2	Cognitive Dysfunction 01/2018 - 01/2018
2	Acute Lung Injury 12/2016 - 11/2014
2	Cerebral Infarction 01/2016 - 06/2015
2	Septic Shock (Toxic Shock Syndrome) 07/2010 - 05/2004
2	Vascular Calcification 07/2005 - 07/2005
2	Vascular Remodeling 10/2004 - 09/2004
1	Infections 06/2022
1	Carotid Artery Thrombosis 01/2021
1	Brain Infarction 01/2021
1	Stroke (Strokes) 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Atherosclerosis 01/2019

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2004
11	qishen yiqiIBA 01/2021 - 01/2012
10	AlbuminsIBA 06/2022 - 01/2013
9	Messenger RNA (mRNA)IBA 11/2013 - 02/2004
8	Adenosine Triphosphate (ATP)IBA 06/2022 - 01/2013
7	Evans Blue (Blue, Evans)FDA Link 01/2021 - 06/2015
7	CollagenIBA 01/2019 - 11/2004
4	Claudin-5IBA 01/2021 - 12/2016
4	LipopolysaccharidesIBA 01/2019 - 02/2014
4	Adenosine Monophosphate (AMP)IBA 01/2018 - 01/2013
4	CytokinesIBA 01/2018 - 10/2014
3	astragaloside AIBA 06/2022 - 11/2013
3	OccludinIBA 01/2022 - 01/2018
3	cadherin 5IBA 01/2022 - 01/2017
3	notoginsenoside R1IBA 01/2021 - 01/2014
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 06/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2013
3	Insulin (Novolin)FDA Link 01/2019 - 01/2015
3	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2019 - 04/2010
3	Sirtuin 3IBA 01/2019 - 08/2015
3	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2013
3	src-Family KinasesIBA 01/2018 - 06/2015
3	AdrenomedullinIBA 07/2010 - 05/2004
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2006 - 01/2005
3	Peptides (Polypeptides)IBA 09/2005 - 02/2004
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	SirtuinsIBA 01/2021 - 08/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2018
2	Actins (F Actin)IBA 01/2021 - 01/2018
2	Caveolin 1IBA 01/2021 - 01/2017
2	AntioxidantsIBA 01/2019 - 06/2015
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 02/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 02/2014
2	EnzymesIBA 01/2019 - 01/2005
2	oxidized low density lipoproteinIBA 01/2019 - 01/2018
2	salvianolic acidIBA 01/2019 - 10/2014
2	Laminin (Merosin)IBA 01/2018 - 12/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 10/2014
2	Pharmaceutical PreparationsIBA 10/2014 - 04/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2013 - 04/2010
2	ApelinIBA 07/2010 - 01/2006
2	GhrelinIBA 05/2006 - 07/2005
2	Neprilysin (Neutral Endopeptidase)IBA 01/2005 - 05/2004
2	AldosteroneIBA 11/2004 - 10/2004
1	Small Interfering RNA (siRNA)IBA 06/2022
1	PowdersIBA 01/2022
1	Claudin-3IBA 01/2022
1	ClaudinsIBA 01/2022
1	CateninsIBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2021
1	CaveolinsIBA 01/2021
1	ferric chlorideIBA 01/2021
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2021
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2021
1	rho-Associated KinasesIBA 01/2021
1	Dehydroepiandrosterone (DHEA)IBA 01/2021
1	yi-qi-fu-maiIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	ribosomal protein S19IBA 01/2019
1	ImmunosorbentsIBA 01/2019

Therapy/Procedure

5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 10/2014
2	Therapeutics 01/2021 - 12/2016
2	Lasers (Laser) 01/2013 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2021